Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized TrialsP. Andrew, John Hural, L. Naidoo et al.|UNC Libraries|2023Cited by 0
Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal AntibodyDavid Burns, Gail Broder, John Hural et al.|UNC Libraries|2023Cited by 0